Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events
Blood Cancer Journal, Published online: 11 August 2023; doi:10.1038/s41408-023-00891-xReal-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events
Source: Blood Cancer Journal - Category: Hematology Authors: Maymona G. Abdelmagid Aref Al-Kali Mark R. Litzow Kebede H. Begna William J. Hogan Mirinal S. Patnaik Shahrukh K. Hashmi Michelle A. Elliott Hassan Alkhateeb Omer S. Karrar Farah Fleti Mohammed H. Elnayir Candido E. Rivera Hemant S. Murthy James M. Foran Source Type: research
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Hematology | Leukemia | Nilotinib | Tasigna